Rochester v. Reyes, M.D. ( 2015 )


Menu:
  •                                   SUPERIOR COURT
    of the
    STATE OF DELAWARE
    Jeffrey J Clark                                                   Kent C ounty Cou rthouse
    Judge                                                                  38 The G reen
    Dover, DE 19901
    Telephone (302)739-5333
    December 3, 2015
    Bartholomew J. Dalton, Esq.                John D. Balaguer, Esq.
    Andrew C. Dalton, Esq.                     Lindsey E. Anderson, Esq.
    Dalton & Associates PA                     White & Williams LLP
    1106 West 10th Street                      824 N. Market Street, Ste. 902
    Wilmington, DE 19806                       Wilmington, DE 19899
    RE:        Estate of Robert R. Rochester, Jr. v. Reyes, M.D., et al.
    N13C-07-371 JAP
    Dear Counsel:
    Plaintiffs move in limine to admit out-of-court statements allegedly made by
    Christiana Care Health System agents instructing the decedent to stop his coumadin
    regimen. Defendants object to the admission of these statements arguing they are
    hearsay. Plaintiffs argue that the statements are nonhearsay because they are offered
    to prove their effect on the listener and are not offered for the truth of the matter
    asserted. Plaintiffs also move to exclude Defendants’ chart offered to show the
    decedent’s five-year historical INR levels. Plaintiffs argue that the data, and
    accordingly the chart summarizing the data, are irrelevant and also inadmissible
    pursuant to Delaware Rule of Evidence 403.
    The parties submitted letter memoranda to the Court and then argued the issues
    on December 2, 2015. For the reasons below, the Court grants, in part, Plaintiffs’
    motion to admit Christiana Care agents’ alleged statements because they are
    nonhearsay. The Court denies the Plaintiffs’ motion to exclude the decedent
    Plaintiff’s historical INR chart because (1) it is relevant and; (2) it is not inadmissible
    pursuant to DRE 403.
    Est. Of Robert R. Rochester, Jr. v. Carlos E. Reyes, M.D., et al.
    N13C-02-371 JAP
    Page 2
    Background
    This is a medical malpractice case where the Plaintiffs allege that Defendants,
    Dr. Reyes and Delaware Medical Group, were negligent in treating Plaintiff Robert
    Rochester (“decedent”). More specifically, Plaintiffs allege that Dr. Reyes failed to
    appropriately treat decedent’s hyercoagulation condition which in turn caused his
    death.
    On October 12, 2012, the decedent went to the emergency room at Christiana
    Hospital because of a dog bite he suffered while delivering mail. For at least several
    years before the emergency room visit, the decedent took the blood thinner coumadin
    due to a pulmonary embolsim in 2007. Plaintiffs proffer that two separate healthcare
    professionals at Christiana instructed the decedent to stop taking his prescribed
    coumadin until a followup appointment with his primary care provider, Dr. Reyes.
    The decedent visited Dr. Reyes four days after his emergency room visit. Dr.
    Reyes claims that the decedent told him at this visit that he was still taking his
    coumadin. The decedent died of a pulmonary embolism approximately eighteen
    hours after leaving Defendants’ office.
    Christiana Health Services is no longer a party except for purposes of possible
    apportionment of liability purposes, pursuant to a settlement including a joint
    tortfeasor release. The two Christiana Health Services declarants that made the
    statements at issue have not been identified.
    Finally, critical to the second issue in Plaintiff’s motion are the historical INR
    levels of decedent. These levels record the levels of coumadin in a patient’s blood
    to ensure they stay at a level sufficient to achieve the required purpose. During
    decedent’s treatment after the pulmonary embolism in 2007, he regularly received
    blood tests recording these levels. During this greater than five year period, many of
    the INR results were lower than the therapeutic threshold.
    Est. Of Robert R. Rochester, Jr. v. Carlos E. Reyes, M.D., et al.
    N13C-02-371 JAP
    Page 3
    Statements made by Christiana Care employees to discontinue coumadin are
    admissible as nonhearsay provided
    Robert Rochester was present when they were made.
    The statements allegedly made by Christiana Care’s agents to the decedent are
    admissible nonhearsay. The threshold issue in hearsay analysis always starts with
    asking what is the evidence offered to prove. This necessarily gives some flexibility
    to the proponent as evidence often can have more than one purpose. The Plaintiffs
    offer this evidence to show its effect on the listener – the decedent. Namely, the
    evidence is offered to prove that decedent likely stopped taking his coumadin in
    response to the statements.
    As presented to the Court at this juncture, the challenged out-of-court
    statements fall in three categories. First, there are proferred statements made to the
    decedent telling him to stop taking his coumadin with relatives present. Second, there
    is the exchange between decedent’s son and decedent confirming that decedent was
    told to stop taking his coumadin. Third, there is at least one statement Plaintiff may
    seek to offer involving an exchange between decedent’s son Christopher and
    decedent’s brother confirming the statements made by agents of Christiana Care.
    The Defendants argue that all three are offered to prove the truth of the matter
    asserted. Defendants frame the analysis by arguing that the matter asserted is that the
    decedent was in fact taking his coumadin between the hospital visit and the followup
    primary care visit. Furthermore, citing Atkins v. State1 and Sanabria v. State2, the
    Defendants submit that effect on the listener nonhearsay requires that there be some
    independent evidence that the decedent stopped taking his medication as a
    prerequisite to admit nonhearsay in this category.
    The Delaware Supreme Court, as the Federal courts, recognize this category
    of nonhearsay. 3 Furthermore, the key Delaware Supreme Court decision cited by
    1
    Atkins v. State, 
    523 A.2d 539
    (Del. 1987).
    2
    Sanabria v. State, 
    974 A.2d 107
    (Del. 2009).
    3
    
    Atkins, 523 A.2d at 547
    .
    Est. Of Robert R. Rochester, Jr. v. Carlos E. Reyes, M.D., et al.
    N13C-02-371 JAP
    Page 4
    both parties, Atkins v. State, does not require independent corroborating evidence as
    a prerequisite to admission of nonhearsay. 4
    Defendants also rely on Sanabria v. State, arguing that it requires that
    admitting such a statement is conditioned on the availability of other admissible
    evidence that the listener acted in accordance with the instructions. Sanabria,
    however, was decided in the criminal law context where the Confrontation Clause
    was a key concern. There, the State attempted to admit a dispatcher’s statement
    which was the only evidence that a burglar was physically in a home.5 The non-
    testifying dispatcher’s statement about an essential element of a crime violated the
    Confrontation Clause of the Sixth Amendment.6
    The Confrontation Clause, of course, does not apply in this civil context.
    Furthermore, the statements in Sanabria regarding “independent evidence that the
    defendant possessed cocaine” were included in the Delaware Supreme Court’s
    analysis of sufficiency of the evidence for purposes of determining whether the
    Confrontation Clause violation was harmless.7 Lastly, even in the criminal law
    context, Sanabria noted that such testimony could be properly admitted if the trial
    court issues a limiting instruction after conducting a DRE 403 balancing test.8
    Accordingly, the reasoning in Sanabria does not support Defendant’s position in this
    case. Given an absence of any direct authority submitted by the Defendants, the
    Court does not find that independent evidence of action taken by the listener is a
    prerequisite to admission of nonhearsay in this category.9
    4
    
    Id. 5 Id.
    at 121.
    6
    
    Id. at 120.
           7
    
    Id. at 121.
           8
    
    Id. at 116.
           9
    Plaintiff also submits that a pill count from decedent’s pill bottle evidences that he
    stopped taking coumadin. Such evidence, if admitted, would constitute some independent
    evidence regarding decedent’s coumadin regimen during the intervening days at issue.
    Est. Of Robert R. Rochester, Jr. v. Carlos E. Reyes, M.D., et al.
    N13C-02-371 JAP
    Page 5
    Defendants argue that the statements at issue could also tend to prove the truth
    of the matter asserted. They are correct. However, nonhearsay statements involving
    effect on the listener “frequently have an impermissible hearsay aspect as well as the
    permissible nonhearsay aspect.”10 If the evidence is not barred pursuant to DRE 403,
    such evidence is properly admitted, subject to an appropriate limiting instruction.11
    As noted in a well-recognized federal evidence and practice treatise, the general
    evidentiary rule is that instructions to an individual to do something are not hearsay. 12
    Here, the instructions to the decedent to stop taking his coumadin are not hearsay.
    Before admitting the evidence, the Court is required to perform a DRE 403
    balancing test. Statements made to the decedent by health care professionals that he
    should stop taking his coumadin are probative circumstantial evidence that he took
    that action. The risk of unfair prejudice cannot be said to substantially outweigh the
    probative value of this evidence. The Court, however, will issue a limiting
    instruction at an appropriate time during the course of the trial to emphasize its
    limited purpose to the jury.
    To the extent that any Christiana Care agent’s out-of-court statements were
    made to the decedent’s relatives outside the presence of the decedent, they will be
    barred pursuant to DRE 403. The relevance as to such statements effect on
    Christopher or Ronald Rochester is minimal at best. In fact, the Court does not
    appreciate any relevance of actions taken by them as a result of instructions given to
    the decedent regarding his medication. Moreover, the substantial risk of confusing
    the issues and unfairly prejudicing the Defendants would substantially outweigh any
    probative value of such evidence If the decedent was present during such statements,
    they are admissible for the limited purpose offered. If the decedent was not, they are
    not admissible.
    Finally, the statements identified by Defendants between Christopher Rochester
    and his father will similarly be admitted. Defendant’s argues that these statements
    10
    McCormick on Evidence § 249 (3rd ed).
    11
    
    Id. 12 30B
    Federal Practice and Procedure “Definition of Hearsay” § 7005, at 73-76 (2011).
    Est. Of Robert R. Rochester, Jr. v. Carlos E. Reyes, M.D., et al.
    N13C-02-371 JAP
    Page 6
    involve multiple levels of hearsay. At each level analyzed, the statements in this
    exchange are nonhearsay. They are offered to prove circumstantial evidence of the
    statements effect on the listener – that he was not taking his coumadin during that
    period.
    The Defendant’s chart summarizing Decedent’s Prior INR levels
    is admissible
    Defendants offer into evidence a chart summarizing decedent’s prior INR
    levels to show (1) that decedent’s INR values regularly fluctuated in and out of the
    therapeutic range for greater than five years before his death; (2) that he did not
    experience a pulmonary embolism during the periods his INR was as low or nearly
    as low as alleged in the instant case; (3) that when decedent’s levels were low, Dr.
    Reyes’ practice was to re-test the INR levels and adjust decedent’s dosage; and (4)
    at the times decedent’s levels were as low as the levels involved in this incident, the
    decedent was not hospitalized.
    Plaintiffs oppose its admission based on relevancy. Namely, Plaintiffs
    emphasize that both Defendants’ experts testified in their depositions that the INR
    reading immediately preceding decedent’s office visit with Dr. Reyes was irrelevant
    to whether Dr. Reyes breached the standard of care. Both Defendant’s proffered
    experts, Dr. Skolnick and Dr. Fogarty, testified in depositions that a reasonable doctor
    would not be influenced by the immediately preceding INR result. Thus, Plantiffs
    argue that five years of prior results are likewise irrelevant. Plaintiff’s argument in
    this regard goes to the weight the jury should place on the data. If Dr. Reyes’
    testimony will be as proffered, the chart will be relevant.
    Plaintiffs also object to this evidence based on DRE 403, arguing somewhat
    narrowly that the probative value of any such evidence is substantially outweighed
    by the danger of confusing the issues and by needless presentation of cumulative
    evidence. Here, the data in the chart is confined to the period Dr. Reyes provided
    treatment to the decedent for the condition Plaintiffs allege caused Mr. Rochester’s
    death. Such evidence is probative and the Plaintiffs’ arguments do not convince the
    Court that DRE403 considerations substantially outweigh the data’s relevance.
    Accordingly, the chart will be admitted for at least some of the purposes proffered by
    Defendants. Testimony and argument regarding some of the itemized reasons
    Est. Of Robert R. Rochester, Jr. v. Carlos E. Reyes, M.D., et al.
    N13C-02-371 JAP
    Page 7
    proffered by the Defendants may be limited, however, by expert disclosures,
    discovery responses, and the requirements for expert opinion evidence.
    IT IS SO ORDERED.
    /s/ Jeffrey J Clark
    JJC/dsc
    Via File & ServeXpress
    oc: Prothonotary
    

Document Info

Docket Number: N13C-07-371

Judges: Clark

Filed Date: 12/3/2015

Precedential Status: Precedential

Modified Date: 12/4/2015